About

Subscribe

Contact

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is gaining momentum in clinical settings, with compounds like psilocybin, MDMA, and DMT being studied for their potential to treat PTSD, anxiety, depression, and addiction. This section explores trial data, therapeutic frameworks, FDA designations, and the evolving ethics around integration into psychiatric practice.

Psilocybin EEG Biomarkers

How Psilocybin EEG Biomarkers Reveal Brain Changes

February 13, 2026

Psilocybin Effects

When Psilocybin Effects Depend On The Body Not Just The Brain

February 12, 2026

Antidepressant Effects

How Psilocybin May Create Long-Term Antidepressant Effects Without Permanent Brain Rewiring

February 11, 2026

Intensity Of Psychedelic Experience

What Shapes The Intensity Of Psychedelic Experience

February 4, 2026

Psilocybin Microdosing Creativity

Psilocybin Microdosing Creativity Gains May Be About Quality Not Quantity

February 3, 2026

psilocybin

How Psilocybin May Shape Personality And Personal Values

February 2, 2026

MDMA-assisted therapy for depression

Can MDMA-Assisted Therapy Offer Lasting Relief for Depression

January 26, 2026

data on psychedelics

What Global Safety Data On Psychedelics Really Shows About Physical Risk

January 25, 2026

Psychedelic Treatment

Why Preparation Therapy May Be The Missing Link In Psychedelic Treatment Outcomes

January 24, 2026

intranasal 5-MeO-DMT effects

New Study:  Intranasal 5-MeO-DMT Effects Peak Within Minutes

January 17, 2026

Back Next

Categories

Latest Articles

Join Our Email List

Sign up to receive the latest articles right in your inbox.